1. Home
  2. AISP vs CRBU Comparison

AISP vs CRBU Comparison

Compare AISP & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$3.08

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.82

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
CRBU
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
203.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AISP
CRBU
Price
$3.08
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
806.0K
999.3K
Earning Date
11-17-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,033,886.00
$9,295,000.00
Revenue This Year
$34.52
N/A
Revenue Next Year
$59.54
$4.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.85
$0.66
52 Week High
$7.66
$3.54

Technical Indicators

Market Signals
Indicator
AISP
CRBU
Relative Strength Index (RSI) 33.91 40.56
Support Level $3.47 $1.82
Resistance Level $3.92 $1.91
Average True Range (ATR) 0.23 0.10
MACD 0.02 0.02
Stochastic Oscillator 8.50 28.90

Price Performance

Historical Comparison
AISP
CRBU

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: